1
|
Fernández Lopez A, Luaces Cubells C,
García García JJ and Fernández Pou J: Spanish Society of Pediatric
Emergencies: Procalcitonin in pediatric emergency departments for
the early diagnosis of invasive bacterial infections in febrile
infants: Results of a multicenter study and utility of a rapid
qualitative test for this marker. Pediatr Infect Dis J. 22:895–903.
2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Fitch MT and van de Beek D: Emergency
diagnosis and treatment of adult meningitis. Lancet Infect Dis.
7:191–200. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Andreola B, Bressan S, Callegaro S,
Liverani A, Plebani M and Da Dalt L: Procalcitonin and C-reactive
protein as diagnostic markers of severe bacterial infections in
febrile infants and children in the emergency department. Pediatr
Infect Dis J. 26:672–677. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hatherill M, Tibby SM, Sykes K, Turner C
and Murdoch IA: Diagnostic markers of infection: Comparison of
procalcitonin with C reactive protein and leucocyte count. Arch Dis
Child. 81:417–421. 1999. View Article : Google Scholar : PubMed/NCBI
|
5
|
van der Poll T, de Waal Malefyt R, Coyle
SM and Lowry SF: Antiinflammatory cytokine responses during
clinical sepsis and experimental endotoxemia: Sequential
measurements of plasma soluble interleukin (IL)-1 receptor type II,
IL-10, and IL-13. J Infect Dis. 175:118–122. 1997. View Article : Google Scholar : PubMed/NCBI
|
6
|
Damas P, Reuter A, Gysen P, Demonty J,
Lamy M and Franchimont P: Tumor necrosis factor and interleukin-1
serum levels during severe sepsis in humans. Crit Care Med.
17:975–978. 1989. View Article : Google Scholar : PubMed/NCBI
|
7
|
Damas P, Ledoux D, Nys M, Vrindts Y, De
Groote D, Franchimont P and Lamy M: Cytokine serum level during
severe sepsis in human Il-6 as a marker of severity. Ann Surg.
215:356–362. 1992. View Article : Google Scholar : PubMed/NCBI
|
8
|
Grobmyer SR, Lin E, Lowry SF, Rivadeneira
DE, Potter S, Barie PS and Nathan CF: Elevation of IL-18 in human
sepsis. J Clin Immunol. 20:212–215. 2000. View Article : Google Scholar : PubMed/NCBI
|
9
|
Patel RT, Deen KI, Youngs D, Warwick J and
Keighley MR: Interleukin-6 is a prognostic indicator of outcome in
severe intra-abdominal sepsis. Br J Surg. 81:1306–1308. 1994.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Casey LC, Balk RA and Bone RC: Plasma
cytokine and endotoxin levels correlate with survival in patients
with the sepsis syndrome. Ann Intern Med. 119:771–778. 1993.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Kurt AN, Aygun AD, Godekmerdan A, Kurt A,
Dogan Y and Yilmaz E: Serum IL-1beta, IL-6, IL-8, and TNF-alpha
levels in early diagnosis and management of neonatal sepsis.
Mediators Inflamm. 2007:313972007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ng PC, Li K, Chui KM, Leung TF, Wong RP,
Chu WC, Wong E and Fok TF: IP-10 is an early diagnostic marker for
identification of late-onset bacterial infection in preterm
infants. Pediatr Res. 61:93–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ng PC, Li K, Leung TF, Wong RP, Li G, Chui
KM, Wong E, Cheng FW and Fok TF: Early prediction of sepsis-induced
disseminated intravascular coagulation with interleukin-10,
interleukin-6, and RANTES in preterm infants. Clin Chem.
52:1181–1189. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
15
|
O'Shea JJ and Murray PJ: Cytokine
signaling modules in inflammatory responses. Immunity. 28:477–487.
2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kumar A, Roberts D, Wood KE, Light B,
Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L,
et al: Duration of hypotension before initiation of effective
antimicrobial therapy is the critical determinant of survival in
human septic shock. Crit Care Med. 34:1589–1596. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Martin CM, Priestap F, Fisher H, Fowler
RA, Heyland DK, Keenan SP, Longo CJ, Morrison T, Bentley D and
Antman N: STAR Registry Investigators: A prospective, observational
registry of patients with severe sepsis: The Canadian sepsis
treatment and response registry. Crit Care Med. 37:81–88. 2009.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Brun-Buisson C, Meshaka P, Pinton P and
Vallet B: EPISEPSIS Study Group: EPISEPSIS: A reappraisal of the
epidemiology and outcome of severe sepsis in French intensive care
units. Intensive Care Med. 30:580–588. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Martin GS, Mannino DM, Eaton S and Moss M:
The epidemiology of sepsis in the United States from 1979 through
2000. N Engl J Med. 348:1546–1554. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Vincent JL, Sakr Y, Sprung CL, Ranieri VM,
Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR and Payen D:
Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in
European intensive care units: Results of the SOAP study. Crit Care
Med. 34:344–353. 2006. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hottz ED, Medeiros-de-Moraes IM,
Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto
HC, Weyrich AS, Zimmerman GA, Bozza FA and Bozza PT: Platelet
activation and apoptosis modulate monocyte inflammatory responses
in dengue. J Immunol. 193:1864–1872. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Van Cromphaut SJ, Vanhorebeek I and Van
den Berghe G: Glucose metabolism and insulin resistance in sepsis.
Curr Pharm Des. 14:1887–1899. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yegenaga I, Hoste E, Van Biesen W,
Vanholder R, Benoit D, Kantarci G, Dhondt A, Colardyn F and Lameire
N: Clinical characteristics of patients developing ARF due to
sepsis/systemic inflammatory response syndrome: Results of a
prospective study. Am J Kidney Dis. 43:817–824. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Livaditi O, Kotanidou A, Psarra A,
Dimopoulou I, Sotiropoulou C, Augustatou K, Papasteriades C,
Armaganidis A, Roussos C, Orfanos SE and Douzinas EE: Neutrophil
CD64 expression and serum IL-8: sensitive early markers of severity
and outcome in sepsis. Cytokine. 36:283–290. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wunder C, Eichelbrönner O and Roewer N:
Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome
prediction in severe sepsis? A comparison with APACHE III and SAPS
II. Inflamm Res. 53:158–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Andrade SS, Bispo PJ and Gales AC:
Advances in the microbiological diagnosis of sepsis. Shock.
30(Suppl 1): S41–S46. 2008. View Article : Google Scholar
|
27
|
Tissari P, Zumla A, Tarkka E, Mero S,
Savolainen L, Vaara M, Aittakorpi A, Laakso S, Lindfors M,
Piiparinen H, et al: Accurate and rapid identification of bacterial
species from positive blood cultures with a DNA-based microarray
platform: An observational study. Lancet. 375:224–230. 2010.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Charles PE, Ladoire S, Aho S, Quenot JP,
Doise JM, Prin S, Olsson NO and Blettery B: Serum procalcitonin
elevation in critically ill patients at the onset of bacteremia
caused by either gram negative or gram positive bacteria. BMC
Infect Dis. 8:382008. View Article : Google Scholar : PubMed/NCBI
|
29
|
Skovbjerg S, Martner A, Hynsjö L, Hessle
C, Olsen I, Dewhirst FE, Tham W and Wold AE: Gram-positive and
gram-negative bacteria induce different patterns of cytokine
production in human mononuclear cells irrespective of taxonomic
relatedness. J Interferon Cytokine Res. 30:23–32. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Hessle CC, Andersson B and Wold AE:
Gram-positive and Gram-negative bacteria elicit different patterns
of pro-inflammatory cytokines in human monocytes. Cytokine.
30:311–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Engel A, Mack E, Kern P and Kern WV: An
analysis of interleukin-8, interleukin-6 and C-reactive protein
serum concentrations to predict fever, gram-negative bacteremia and
complicated infection in neutropenic cancer patients. Infection.
26:213–221. 1998. View Article : Google Scholar : PubMed/NCBI
|
32
|
Feezor RJ, Oberholzer C, Baker HV, Novick
D, Rubinstein M, Moldawer LL, Pribble J, Souza S, Dinarello CA,
Ertel W and Oberholzer A: Molecular characterization of the acute
inflammatory response to infections with gram-negative versus
gram-positive bacteria. Infect Immun. 71:5803–5813. 2003.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Berres ML, Trautwein C, Schmeding M,
Eurich D, Tacke F, Bahra M, Neuhaus P, Neumann UP and Wasmuth HE:
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis
progression after liver transplantation for hepatitis C infection.
Hepatology. 53:596–603. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zeremski M, Markatou M, Brown QB, Dorante
G, Cunningham-Rundles S and Talal AH: Interferon gamma-inducible
protein 10: A predictive marker of successful treatment response in
hepatitis C virus/HIV-coinfected patients. J Acquir Immune Defic
Syndr. 45:262–268. 2007.PubMed/NCBI
|
35
|
Reiberger T, Aberle JH, Kundi M,
Kohrgruber N, Rieger A, Gangl A, Holzmann H and Peck-Radosavljevic
M: IP-10 correlates with hepatitis C viral load, hepatic
inflammation and fibrosis and predicts hepatitis C virus relapse or
non-response in HIV-HCV coinfection. Antivir Ther. 13:969–976.
2008.PubMed/NCBI
|
36
|
Conroy AL, Gélvez M, Hawkes M, Rajwans N,
Liles WC, Villar-Centeno LA and Kain KC: Host biomarkers
distinguish dengue from leptospirosis in Colombia: A case-control
study. BMC Infect Dis. 14:352014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Punyadeera C, Schneider EM, Schaffer D,
Hsu HY, Joos TO, Kriebel F, Weiss M and Verhaegh WF: A biomarker
panel to discriminate between systemic inflammatory response
syndrome and sepsis and sepsis severity. J Emerg Trauma Shock.
3:26–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
38
|
Loetscher M, Gerber B, Loetscher P, Jones
SA, Piali L, Clark-Lewis I, Baggiolini M and Moser B: Chemokine
receptor specific for IP10 and Mig: Structure, function, and
expression in activated T-lymphocytes. J Exp Med. 184:963–969.
1996. View Article : Google Scholar : PubMed/NCBI
|
39
|
Hsieh MF, Lai SL, Chen JP, Sung JM, Lin
YL, Wu-Hsieh BA, Gerard C, Luster A and Liao F: Both CXCR3 and
CXCL10/IFN-inducible protein 10 are required for resistance to
primary infection by dengue virus. J Immunol. 177:1855–1863. 2006.
View Article : Google Scholar : PubMed/NCBI
|